Lillia, the AI startup, introduced its platform to empower individuals with diabetes

On Monday, Lillia, an AI firm that is revolutionizing chronic care for a healthier world, unveiled its platform, which enables people with diabetes and other chronic disorders to lead satisfying lives. 

Healthcare providers, insurers, businesses, and public sector organizations may efficiently manage chronic diseases with Lillia's clinically validated, AI-powered platform. 

Additionally, Lillia revealed that it has been awarded a US $1.7 million grant by the Qatar Research, Development and Innovation (QRDI) Council to create the first chronic condition-focused digital twin in the GCC. 

Lillia uses AI in conjunction with knowledgeable human coaches, such as psychologists, dietitians, and physicians, to develop a treatment plan that is hyperlocalized to a person's metabolism and way of life. It helps them form enduring micro-habits supported by validated clinical results. 

Lillia also presented their concept of a chronic care digital twin combined with AI agents at Web Summit Qatar. This will enable applications in real-time risk monitoring, precision medication, and other use cases, as well as provide predictive capabilities to the platform.